InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

Current share price for NOX : $0.089 0.005 (5.95%)+

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$27 Results of Meeting 21 Nov 2018 2:26PM $0.510 $0.089 fallen by 82.55%
$27 Appointment of Mr John Moore as Non-Executive Director 21 Nov 2018 12:28PM $0.505 $0.089 fallen by 82.38%
$27 NOX 2018 AGM Presentations 21 Nov 2018 10:57AM $0.505 $0.089 fallen by 82.38%
$27 NOX 2018 AGM Information 20 Nov 2018 9:11AM $0.550 $0.089 fallen by 83.82%
$27 NOX to Present Clinical Data at COSA Annual Meeting 13 Nov 2018 9:10AM $0.550 $0.089 fallen by 83.82%
$27 Corporate Presentation 8 Nov 2018 9:20AM $0.535 $0.089 fallen by 83.36%
$27 Appendix 4C - quarterly 26 Oct 2018 9:46AM $0.600 $0.089 fallen by 85.17%
$27 NOX makes key executive appointment 22 Oct 2018 9:13AM $0.680 $0.089 fallen by 86.91%
$27 Notice of Annual General Meeting & Proxy Form 5 Oct 2018 9:46AM $0.590 $0.089 fallen by 84.92%
$27 Noxopharm Releases Report on Key Progress of Subsidiary 4 Oct 2018 10:29AM $0.610 $0.089 fallen by 85.41%
$27 Section 708 Certificate 2 Oct 2018 3:49PM $0.640 $0.089 fallen by 86.09%
$27 Appendix 3B 2 Oct 2018 3:47PM $0.640 $0.089 fallen by 86.09%
$27 Change of Director's Interest Notice - PM 28 Sep 2018 6:28PM $0.650 $0.089 fallen by 86.31%
$27 Section 708 Certificate 28 Sep 2018 3:42PM $0.650 $0.089 fallen by 86.31%
$27 Appendix 3B 28 Sep 2018 3:41PM $0.650 $0.089 fallen by 86.31%
$27 Change of Registry Address: Automic P/L - Sydney Office 28 Sep 2018 12:27PM $0.670 $0.089 fallen by 86.72%
$27 Annual Report to shareholders 27 Sep 2018 9:22AM $0.710 $0.089 fallen by 87.46%
$27 Corporate Governance Statement - Appendix 4G 27 Sep 2018 9:18AM $0.710 $0.089 fallen by 87.46%
$27 Corporate Governance Statement - 2018 27 Sep 2018 9:16AM $0.710 $0.089 fallen by 87.46%
$27 NOX Subsidiary Announces Important Drug Discovery 24 Sep 2018 10:16AM $0.620 $0.089 fallen by 85.65%
$27 NOX to support expanded LuPIN study 5 Sep 2018 9:25AM $0.635 $0.089 fallen by 85.98%
$27 Appendix 4E and Audited Financial Statements 30 Aug 2018 12:14PM $0.655 $0.089 fallen by 86.41%
$27 Nyrada-Key progress with cholesterol-lowering drug candidate 27 Aug 2018 9:10AM $0.640 $0.089 fallen by 86.09%
$27 VEYONDA - Registered Trade Mark for NOX66 20 Aug 2018 1:09PM $0.620 $0.089 fallen by 85.65%
$27 NOX Corporate Presentation FNN-Shaw&Partners Investor Event 14 Aug 2018 1:54PM $0.595 $0.089 fallen by 85.04%

576 - 600 of 796 results

Page 24 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.